isirv Antiviral Group
Meeting Reports
|
An ISIRV-WHO Virtual Conference – ‘COVID-19, Influenza and RSV: Surveillance-Informed Prevention and Treatment’
This 3-day virtual conference was held on 19-21 October 2021. A Conference Report was published in Antiviral Research and can be found here
|
|
Therapeutics for COVID-19, a special virtual conference, 6-8 October 2020
The 3-day programme addressed the latest advances in the development of antivirals and other therapeutics for use against COVID-19 and possibilities for improved clinical management. A conference report and oral and e-poster presentations are available.Read more
|
|
AVG Polymerase Inhibitor Resistance Meeting, at the Offices of the Task Force for Global Health, Atlanta, USA, 7-8 August 2019.The participants at this small specialist meeting, including public health, academic and corporate representatives who are conducting studies on the new antivirals targeting the influenza RNA polymerase, met to discuss the impact of resistance to these inhibitors. A report of the meeting is incorporated in an Assessment of the Current State of the Art report published in Antiviral Research and now on the AVR journal web site as a highlighted article. Read more
|
|
The 6th isirv-AVG conference on Advances in Respiratory Virus Therapeutics was held in Washington DC, USA 13-15 November 2018
The meeting report is available here
|
|
A symposium, Influenza 2018: Centenary of the 1918 Pandemic, organised by ISIRV, WHO and The Francis Crick Institute, was held in London, UK 24-26 June 2018
A brief report is available - read more
|
|
The 5th isirv-AVG conference on Prevention and Treatment of Respiratory Viral Infections was held in Shanghai, China 14-16 June 2017
The meeting report is available here
|
|
A training workshop on Genetic Analyses of Influenza Viruses, organised by ISIRV-AVG, GISAID and WHO was held at Northwestern University, Chicago 29 August 2016
Programme attached
|
|
A two-day training workshop on Genetic Analyses of Influenza Viruses, organised by ISIRV-AVG, GISAID, WHO and the Hong Kong Polytechnic University, was held in Hong Kong 21-22 November 2015
A brief report is available here
|
|
The 4th isirv-AVG conference on Novel Antiviral Therapies for Influenza and Other Respiratory Viruses: Bench To Bedside was held in Austin, Texas 2-4 June 2015
A brief report is available here
|
|
A workshop, organised by ISIRV-AVG, GISAID and PREDEMICS, on Next Generation Sequencing Of Viruses was held in Paris, France 20-21 May 2015
A brief report is available here
|
|
The 3rd isirv-AVG conference on Influenza and Other Respiratory Virus Infections: Advances in Clinical Managementwas held in Tokyo on 4-6 June 2014.
|
|
An AVG discussion meeting on Clinical Trial Endpoints for Studies of Antivirals in Hospitalised and At-Risk Patients was held on 8 September 2013 in Cape Town during the Options for the Control of Influenza VIII conference.
A short training workshop on Sequence Analysis and Detection of Antiviral Resistance was co-organised with GISAID, with support from WHO, on 7 September 2013 in Cape Town during the Options for Control of Influenza VIII conference. A report is available here |
|
The 2nd isirv-AVG conference on Severe Influenza: Burden, Pathogenesis and Management held in Hanoi on 29-31 October 2012, was co-organised with The National Institute of Hygiene and Epidemiology, with a focus on South East Asia.
The conference programme, abstract book and meeting summary are available here
Proceedings, published as a special issue of Influenza and Other Respiratory Viruses, are availablehere
|
| The inaugural meeting onInfluenza Antivirals: Efficacy and Resistance in Rio de Janeiro on 8-10 November 2011 was co-organised with the Oswaldo Cruz Foundation with a focus on Latin America.A summary of the meeting is available here Proceedings, published as a special issue of Influenza and Other Respiratory Viruses, are availablehere |
|
The isirv-AVG predecessor organisation, NISN (the Neuraminidase Inhibitor Susceptibility Network), published an overview of antiviral drug resistance data presented at Options for the Control of Influenza VII, Hong Kong in September 2010. The meeting report can be found here |
| Additional resources from meetings are available in the members' area of the isirv website |